1)Pathak M, Diep PP, Lai X et al:Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation. Bone Marrow Transplant 53:863-872, 2018
2)日本造血細胞移植学会:造血細胞移植ガイドラインGVHD(第4版).2018
3)Arai S, Jagasia M, Storer B et al:Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 118:4242-4249, 2011
4)Ratanatharathorn V, Ayash L, Lazarus HM et al:Chronic graft-versus-host disease:clinical manifestation and therapy. Bone Marrow Transplant 28:121-129, 2001
5)Kawano N, Gondo H, Kamimura T et al:Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients. Int J Hematol 78:370-373, 2003
6)Cheng X, Huang R, Huang S et al:Recent advances in ocular graft-versus-host disease. Front in Immunol 14:1092108, 2023
7)Sabti S, Halter JP, Braun Fränkl BC et al:Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD. Bone Marrow Transplant 47:981-984, 2012
8)Nassiri N, Eslani M, Panahi N et al:Ocular graft versus host disease following allogeneic stem cell transplantation:a review of current knowledge and recommendations. J Ophthalmic Vis Res 8:351-358, 2013
9)Wang Y, Ogawa Y, Dogru M et al:Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant 41:293-302, 2008
10)Tam PM, Young AL, Cheng LL et al:Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD. Bone Marrow Transplant 45:957-958, 2010
11)Boström L, Ringdén O, Jacobsen N et al:A European multicenter study of chronic graft-versus-host disease. The role of cytomegalovirus serology in recipients and donors—acute graft-versus-host disease, and splenectomy. Transplantation 49:1100-1105, 1990